Literature DB >> 14705227

Takayasu's arteritis: vascular interventions and outcomes.

Patrick Liang1, Millicent Tan-Ong, Gary S Hoffman.   

Abstract

OBJECTIVE: To provide an analysis of outcomes of vascular interventions in 20 patients with Takayasu's arteritis (TA) who received care at the Cleveland Clinic Foundation between 1979 and 2001.
METHODS: We performed a retrospective chart review. The primary outcome measure of our review was patency of vessels as assessed by repeat invasive angiography or magnetic resonance angiography. The secondary outcome measures included periprocedural complications, morbidity, and mortality. Interventions included bypass grafts, patch angioplasty, endarterectomy, percutaneous transluminal angioplasty (PTA), or stent placement.
RESULTS: Sixty-two revascularization procedures were performed in 20 patients. Followup evaluations were available for 52 procedures. Eleven of 31 bypass grafts restenosed or occluded between one day to 168 months after surgery. Three of 7 PTA and 5 of 7 stents restenosed or became occluded after 1-72 months and 2-45 months of followup, respectively. There were no deaths associated with revascularization procedures.
CONCLUSION: Despite providing short term benefit, endovascular revascularization procedures are associated with a high failure rate in patients with TA.

Entities:  

Mesh:

Year:  2004        PMID: 14705227

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

1.  Takayasu's arteritis: clinical features and outcomes of 125 patients in China.

Authors:  Xiao-Liang Cong; Sheng-Ming Dai; Xiang Feng; Zhi-Wei Wang; Qing-Sheng Lu; Liang-Xi Yuan; Xian-Xian Zhao; Dong-Bao Zhao; Zai-Ping Jing
Journal:  Clin Rheumatol       Date:  2010-06-30       Impact factor: 2.980

2.  The results of treatment in renal artery stenosis due to Takayasu disease: comparison between surgery, angioplasty, and stenting. A monocentrique retrospective study.

Authors:  H Kinjo; A Kafa
Journal:  G Chir       Date:  2015 Jul-Aug

Review 3.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

4.  Emergency renal artery stenting in acute anuric renal failure in children with Takayasu's arteritis.

Authors:  Nageswara Rao Koneti; Nipun Mahajan; Shweta Bakhru; Sudeep Verma; Pallavi Kathare
Journal:  Indian Heart J       Date:  2013-09-05

5.  Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Authors:  Haner Direskeneli; Sibel Z Aydin; Tanaz A Kermani; Eric L Matteson; Maarten Boers; Karen Herlyn; Raashid A Luqmani; Tuhina Neogi; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

Review 6.  Takayasu arteritis--advances in diagnosis and management.

Authors:  Justin C Mason
Journal:  Nat Rev Rheumatol       Date:  2010-07       Impact factor: 20.543

7.  A case of a patient with Takayasu arteritis treated with left subclavian artery stent implantation.

Authors:  Young Kyun Choi; Young Ok Jung; Han Myun Kim; Min-Kyung Kang
Journal:  J Cardiol Cases       Date:  2015-07-08

Review 8.  Takayasu arteritis presenting as epileptic seizures: a case report and brief review of the literature.

Authors:  Marios A Ioannides; Christos Eftychiou; George M Georgiou; Evagoras Nicolaides
Journal:  Rheumatol Int       Date:  2008-10-22       Impact factor: 2.631

9.  Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis.

Authors:  M Both; P M Aries; S Müller-Hülsbeck; T Jahnke; P J Schäfer; W L Gross; M Heller; M Reuter
Journal:  Ann Rheum Dis       Date:  2006-02-07       Impact factor: 19.103

10.  Coexistence of pheochromocytoma with uncommon vascular lesions.

Authors:  Sunil Kumar Kota; Siva Krishna Kota; Lalit Kumar Meher; Sruti Jammula; Sandip Panda; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.